AstraZeneca PLC AZN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:49 AM EDT
76.42quote price arrow up+0.01 (+0.01%)
Volume
56,494
Close
76.41quote price arrow up+0.53 (+0.70%)
Volume
4,235,792
52 week range
60.47 - 76.80
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close76.41
  • 52 Week High76.80
  • 52 Week High Date05/01/24
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24

Key Stats

  • Market Cap236.905B
  • Shares Out3.10B
  • 10 Day Average Volume6.80M
  • Dividend1.45
  • Dividend Yield1.90%
  • Beta0.49
  • YTD % Change13.45

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close76.41
  • 52 Week High76.80
  • 52 Week High Date05/01/24
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24
  • Market Cap236.905B
  • Shares Out3.10B
  • 10 Day Average Volume6.80M
  • Dividend1.45
  • Dividend Yield1.90%
  • Beta0.49
  • YTD % Change13.45

RATIOS/PROFITABILITY

  • EPS (TTM)2.03
  • P/E (TTM)37.68
  • Fwd P/E (NTM)14.31
  • EBITDA (TTM)13.775B
  • ROE (TTM)17.29%
  • Revenue (TTM)47.611B
  • Gross Margin (TTM)82.17%
  • Net Margin (TTM)13.31%
  • Debt To Equity (MRQ)92.27%

EVENTS

  • Earnings Date07/25/2024(est)
  • Ex Div Date02/22/2024
  • Div Amount0.985
  • Split Date-
  • Split Factor-

Profile

MORE
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects....
Michel Demare
Non-Executive Independent Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin M.D.
Chief Financial Officer, Executive Director
Ruud Dobber Ph.D.
Executive Vice President - BioPharmaceuticals Business Unit
Susan Galbraith
Executive Vice President - Oncology and Research and Development
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
NVS
Novartis AG
97.50+0.37+0.38%
ABBV
AbbVie Inc
161.72-0.92-0.57%
RHHBY
Roche Holding AG
29.75UNCHUNCH
SNY
Sanofi SA
50.03+0.80+1.63%
PFE
Pfizer Inc
27.18+1.56+6.09%